{
    "clinical_study": {
        "@rank": "104087", 
        "arm_group": [
            {
                "arm_group_label": "Ropivacain", 
                "arm_group_type": "Active Comparator", 
                "description": "Ropicacain 3,75 mg/ml 15 ml x 4 when placing the Bilateral Dual Transverus Abdominis Plane block"
            }, 
            {
                "arm_group_label": "Isotonic potassium chloride", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Isotonic potassium chloride 15 ml x 4 when placing the bilateral dual transverus abdominis plane block."
            }
        ], 
        "brief_summary": {
            "textblock": "To evaluate the effects of bilateral dual transversus abdominis plane block on postoperative\n      pain after robotic assited laparoskopic surgery and measure the plasma-level of ropivacain\n      after the bilateral dual transversus abdominis plane block."
        }, 
        "brief_title": "Bilateral Dual Transversus Abdominis Plane Block for Robotic Assisted Laparoscopic Surgery", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Pain Treatment", 
            "Robotic Assisted Laparoscopic Surgery", 
            "Bilateral Dual Transversus Abdominis Plane Block"
        ], 
        "condition_browse": {
            "mesh_term": "Pain, Postoperative"
        }, 
        "detailed_description": {
            "textblock": "After randomisation patients for robotic assisted laparoscopic surgery will receive\n      bilateral dual transversus abdominis plane block containing either ropivacain or isotonic\n      potassium chloride.\n\n      The investigators will record pain-score, opioid-consumption and sensibility on the\n      abdominal wall in the postoperative periode.\n\n      Also a blood sample will be taken at 15, 30, 60, 120 and 240 minutes after the block in\n      order to measure the plasma-level of ropivacain after bilateral dual transversus abdominis\n      plane block.\n\n      The investigators assume that there will be significant effect on postoperative pain and\n      that the level of plasma-ropivacain will be acceptable."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients scheduled for robotic assisted laparoscopis surgery\n\n          -  acceptance to participate\n\n        Exclusion Criteria:\n\n          -  allergies to local analgetics\n\n          -  daily use of strong opioids"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 19, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01760161", 
            "org_study_id": "20120042"
        }, 
        "intervention": [
            {
                "arm_group_label": "Ropivacain", 
                "description": "Ropicacain 3,75 mg/ml 15 ml x 4 when placing the Bilateral Dual Transverus Abdominis Plane block", 
                "intervention_name": "Ropivacaine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Isotonic potassium chloride", 
                "description": "Isotonic potassium chloride 15 ml x 4 when placing the bilateral dual transverus abdominis plane block.", 
                "intervention_name": "Isotonic potassium chloride", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Ropivacaine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "postoperative pain", 
            "opioid consumption", 
            "termanalgesia", 
            "plasmaropivacain level"
        ], 
        "lastchanged_date": "January 2, 2013", 
        "location": {
            "contact": {
                "email": "niheb@rn.dk", 
                "last_name": "Nils Bjerregaard, M.D", 
                "phone": "004522860649"
            }, 
            "facility": {
                "address": {
                    "city": "Aalborg", 
                    "country": "Denmark", 
                    "state": "Region Nord", 
                    "zip": "9000"
                }, 
                "name": "Aalborg Hospital"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "official_title": "A Randomised, Double-blind Study to Evaluate the Effect of Bilateral Dual Transversus Abdominis Plane Block on Postoperative Pain and Plasma Concentration of Ropivacaine After Robotic Assisted Laparoscopic Surgery", 
        "other_outcome": [
            {
                "measure": "Thermoanalgesia at dermatome-level th6-th12", 
                "safety_issue": "No", 
                "time_frame": "1 hour after bilateral dual transversus abdominis plane block"
            }, 
            {
                "measure": "Plasma-ropivacain level", 
                "safety_issue": "Yes", 
                "time_frame": "15, 30, 60, 120 and 240 mins after the block"
            }
        ], 
        "overall_contact": {
            "email": "niheb@rn.dk", 
            "last_name": "Nils Bjerregaard, M.D.", 
            "phone": "004522860649"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "Denmark: The Danish National Committee on Biomedical Research Ethics", 
                "Denmark: Ethics Committee", 
                "Denmark: Danish Dataprotection Agency"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Pain-score on numerical rating scale", 
            "safety_issue": "No", 
            "time_frame": "4 hours after surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01760161"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Aalborg Hospital", 
            "investigator_full_name": "Nils Bjerregaard", 
            "investigator_title": "Consultant Anestetist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Administration of opioids", 
                "safety_issue": "No", 
                "time_frame": "The first 24 hours after surgery."
            }, 
            {
                "measure": "Pain-score on numerical rating scale", 
                "safety_issue": "No", 
                "time_frame": "8 hours after surgery"
            }, 
            {
                "measure": "Pain-score on numerical rating scale", 
                "safety_issue": "No", 
                "time_frame": "24 hours after surgery"
            }
        ], 
        "source": "Aalborg Universityhospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Aalborg Universityhospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}